Skip to main content
logo
Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.190
+0.025 (2.15%)
Sep 9, 2026, 6:08 PM HKT

Cloudbreak Pharma Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1,0054,362---
Market Cap Growth
-76.28%----
Enterprise Value
7046,976---
Last Close Price
1.195.20---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
476.432215.23---
PB Ratio
3.059.27---
P/TBV Ratio
3.059.27---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
-3542.65---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.150.01-1.10-1.23-0.76
Net Debt / Equity Ratio
-0.91-0.95-1.00-1.00-0.22
Net Debt / EBITDA Ratio
0.320.54-9.68-7.03-1.34
Net Debt / FCF Ratio
-1.11-13.19-11.40-1.52
Asset Turnover
0.010.010.200.01-
Quick Ratio
3.7210.090.090.190.35
Current Ratio
4.2910.680.100.190.35
Return on Assets (ROA)
-190.68%-125.66%-44.38%-32.23%-
Return on Capital Employed (ROCE)
-289.70%-176.90%10.60%14.40%16.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-94.25%-12.07%---
FCF Yield
--9.23%---
Buyback Yield / Dilution
-77.73%-38.15%-2.78%-0.86%-